Russell Investments Group Ltd. Sells 182,128 Shares of Quanterix Corporation $QTRX

Russell Investments Group Ltd. lowered its holdings in shares of Quanterix Corporation (NASDAQ:QTRX) by 30.0% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 424,659 shares of the company’s stock after selling 182,128 shares during the period. Russell Investments Group Ltd.’s holdings in Quanterix were worth $2,824,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the business. State of Wyoming bought a new position in shares of Quanterix during the 1st quarter worth approximately $47,000. Quantbot Technologies LP lifted its position in shares of Quanterix by 245.9% during the 1st quarter. Quantbot Technologies LP now owns 11,272 shares of the company’s stock valued at $73,000 after acquiring an additional 8,013 shares during the period. Vanguard Personalized Indexing Management LLC boosted its stake in Quanterix by 40.5% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 15,024 shares of the company’s stock worth $100,000 after acquiring an additional 4,330 shares in the last quarter. Peddock Capital Advisors LLC acquired a new stake in Quanterix in the second quarter worth $117,000. Finally, XTX Topco Ltd grew its holdings in Quanterix by 49.2% in the first quarter. XTX Topco Ltd now owns 23,017 shares of the company’s stock worth $150,000 after purchasing an additional 7,595 shares during the period. 86.48% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages have recently weighed in on QTRX. Canaccord Genuity Group reiterated a “hold” rating and set a $5.00 price objective (down previously from $12.00) on shares of Quanterix in a report on Monday, August 11th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Quanterix in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Quanterix has a consensus rating of “Hold” and a consensus target price of $10.33.

Quanterix Trading Down 1.0%

Shares of NASDAQ:QTRX opened at $7.55 on Tuesday. The stock has a market cap of $352.66 million, a PE ratio of -3.24 and a beta of 1.01. The stock’s fifty day simple moving average is $5.98 and its two-hundred day simple moving average is $5.65. Quanterix Corporation has a 1-year low of $4.05 and a 1-year high of $12.41.

Quanterix (NASDAQ:QTRX) last posted its earnings results on Monday, November 10th. The company reported ($0.36) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.23) by ($0.13). The firm had revenue of $40.23 million during the quarter, compared to the consensus estimate of $37.85 million. Quanterix had a negative return on equity of 21.34% and a negative net margin of 73.47%. On average, sell-side analysts forecast that Quanterix Corporation will post -0.98 earnings per share for the current fiscal year.

Quanterix Company Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.